3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Leukemia, Myeloid, Acute
14
Myelodysplastic Syndromes
9
Recurrence
7
Multiple Myeloma
7
Pancreatic Neoplasms
6
Ovarian Neoplasms
6
Lymphoma
6
Lymphoma, Non-Hodgkin
5
Lymphoma, B-Cell
5
Colorectal Neoplasms
5
Burkitt Lymphoma
5
Stomach Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Hodgkin Disease
4
Hematologic Neoplasms
4
Sarcoma
3
Osteosarcoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, B-Cell
3
Leukemia
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urogenital Neoplasms
2
Triple Negative Breast Neoplasms
2
Thymoma
2
Rectal Neoplasms
2
Interventions
tislelizumab
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Simpson-Golabi-Behmel syndrome
×
fludarabine
×
30 days
×
Clear all
No trials found.